title: Comparison of the Roche Cobas® 4800 HPV assay to Roche Amplicor for detection of high-risk human papillomavirus.
abstract: Roche Amplicor HPV (AMP) had previously been used for detection of high-risk human papillomavirus (HR-HPV) in epidemiological and clinical studies. As this assay is no longer available, we compared its performance using PreservCyt samples from women aged of 18-24 years attending for routine cervical cytology screening to Roche Cobas® 4800 (Cobas) to determine if subsequent studies could continue using the Cobas assay. Overall 507 samples were tested on Cobas and compared to previous AMP results, with discrepant samples tested on Roche Linear Array.
  
  
  RESULTS
  Overall, agreement between the Cobas and AMP for the presence of HR HPV types was very high (κ = 0.81) (95 % CI: 0.76 - 0.87) with percentage agreement of 91.57 %. Cobas is comparable to AMP for the detection of HR-HPV types in a community recruited cohort of healthy women.
authors.affiliation: Regional HPV Lab Net Reference Laboratory, Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia. sam.phillips@mcri.edu.au.|Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Bio 21 Institute, Parkville, 3052, Australia. sam.phillips@mcri.edu.au.|Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia. sam.phillips@mcri.edu.au.
authors.forename: S
authors.initials: S
authors.lastname: Phillips
authors.affiliation: Regional HPV Lab Net Reference Laboratory, Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia.|Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia.
authors.forename: A M
authors.initials: AM
authors.lastname: Cornall
authors.affiliation: Regional HPV Lab Net Reference Laboratory, Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia.|Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia.
authors.forename: D A
authors.initials: DA
authors.lastname: Machalek
authors.affiliation: Regional HPV Lab Net Reference Laboratory, Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia.|Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia.|Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
authors.forename: S M
authors.initials: SM
authors.lastname: Garland
authors.affiliation: Family Planning New South Wales, Ashfield, NSW, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Bateson
authors.affiliation: Family Planning Western Australia, Northbridge, WA, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Garefalakis
authors.affiliation: Regional HPV Lab Net Reference Laboratory, Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia.|Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia.|Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
authors.forename: S N
authors.initials: SN
authors.lastname: Tabrizi
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000379:methods* / Q000592:standards*; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000821:virology; D011933:Reagent Kits, Diagnostic / Q000592:standards* / Q000821:virology*; D015203:Reproducibility of Results; D055815:Young Adult
chemical_list: D011933:Reagent Kits, Diagnostic